TargeTrust Biotech.

Universal Early Stage Cancer Screening and Universal Cancer-Specific Drug Development 

 # Vision and Mission:

     We universal cancer-specific drugs. Our products can greatly reduce the global cancer problem. The world’s only methods for: 

1. Producing universal cancer-specific drugs and high-resolution tumor imaging agents.

2. Universal early stage cancer screening to cut tumors away, making cancer cured easily.

3. Real-time therapy resistance detection. Guiding correct therapy. Preventing patients from taking ineffective drugs.

4. Guiding precision dosing. Reducing drug side-effects in cancer therapy.

5. Detecting early cancer relapse to timely treat it.

6. Real-time cancer action detection.

# Problems in Caner Treatment:

1. Most cancers are detected too late by current methods, making cancer hard to treat.

2. Therapy resistance:30～70% treating drugs become ineffective; patients take ineffective drugs; delay therapy; hightly lethal.

3. Drug side-effects: Patients uncomfortable; may disrupt therapy; cause other diseseases; sometime lethal.

4. Current methods (CT, MRI, PET, CTC & ctDNA liquid biopsies, traditional biomarkers, CancerSEEK, Grail MCED Test) assay cancer and cancer therapy response at cancer progression stage (increased tumor size, tumor invade other organs), these take many months, too late, delaying therapy. The sensitivities of current methods in detecting early stage cancer are low.

 # Our Invention-1:  

     Tumor signal transductions stimulate cancer development. Tumor signal transductions take less than 1 hour and sustained. We create a novel medical field "Tumor Signal Transduction-Liquid Biopsy" to assay tumor signal transduction in blood. It is the world's only method to detect cancer development, therapy resistance, and precision dosing, in real time. 

# Our Invention-2:   

    Universal cancer-specific drugs are effective to all patients and can completely kill all tumors in the bodies of patients, increasing therapy efficacy, decreasing therapy resistance and cancer relapse.  We invent a method to produce universal cancer-specific drugs.

       Our inventions lead the future of cancer care, opening up a huge new pharmaceutical industry.

Invention-1: Tumor Signal Transduction-Liquid Biopsy

Clinical Trials

Competitive Analysis

Patents

Contact: jiangmwd@gmail.com